11564005

Source:http://linkedlifedata.com/resource/pubmed/id/11564005

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0010346, umls-concept:C0205210, umls-concept:C0596545, umls-concept:C0666743, umls-concept:C1524063
pubmed:issue	10
pubmed:dateCreated	2001-9-20
pubmed:abstractText	Infliximab is an established treatment for steroid-resistant and fistulating Crohn's disease. Although efficacy has been shown in clinical trials, financial implications often limit its use and limited data exist regarding clinical practice.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8707234
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Gastrointestinal Agents, http://linkedlifedata.com/resource/pubmed/chemical/Steroids, http://linkedlifedata.com/resource/pubmed/chemical/infliximab
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	0269-2813
pubmed:author	pubmed-author:ArnottI DID, pubmed-author:GhoshSS, pubmed-author:McDonaldDD, pubmed-author:WilliamsAA
pubmed:issnType	Print
pubmed:volume	15
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1639-46
pubmed:dateRevised	2004-11-17
pubmed:meshHeading	pubmed-meshheading:11564005-Adolescent, pubmed-meshheading:11564005-Adult, pubmed-meshheading:11564005-Aged, pubmed-meshheading:11564005-Anti-Inflammatory Agents, pubmed-meshheading:11564005-Antibodies, Monoclonal, pubmed-meshheading:11564005-Biological Markers, pubmed-meshheading:11564005-Celiac Disease, pubmed-meshheading:11564005-Cohort Studies, pubmed-meshheading:11564005-Crohn Disease, pubmed-meshheading:11564005-Drug Therapy, Combination, pubmed-meshheading:11564005-Female, pubmed-meshheading:11564005-Gastrointestinal Agents, pubmed-meshheading:11564005-Humans, pubmed-meshheading:11564005-Intestinal Fistula, pubmed-meshheading:11564005-Male, pubmed-meshheading:11564005-Middle Aged, pubmed-meshheading:11564005-Pouchitis, pubmed-meshheading:11564005-Prognosis, pubmed-meshheading:11564005-Prospective Studies, pubmed-meshheading:11564005-Pyoderma Gangrenosum, pubmed-meshheading:11564005-Steroids, pubmed-meshheading:11564005-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	Clinical use of Infliximab in Crohn's disease: the Edinburgh experience.
pubmed:affiliation	Gastrointestinal Unit, Western General Hospital, University of Edinburgh, Edinburgh EH4 2XU, UK. iarnott@ed.ac.uk
pubmed:publicationType	Journal Article, Clinical Trial